Medications in pulmonary insufficiency due to restrictive ventilatory impairment and alveolar-capillary block syndrome.
D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D005203:Farmer's Lung / Q000188:drug therapy; D014890:Granulomatosis with Polyangiitis / Q000188:drug therapy; D006486:Hemosiderosis / Q000188:drug therapy; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D008206:Lymphatic Diseases / Q000188:drug therapy; D010102:Oxygen Inhalation Therapy; D011009:Pneumoconiosis / Q000188:drug therapy; D010488:Polyarteritis Nodosa / Q000188:drug therapy; D011649:Pulmonary Alveolar Proteinosis / Q000188:drug therapy; D011657:Pulmonary Eosinophilia / Q000188:drug therapy; D011658:Pulmonary Fibrosis / Q000188:drug therapy; D011660:Pulmonary Heart Disease / Q000188:drug therapy; D011693:Purpura / Q000188:drug therapy; D011832:Radiation Injuries / Q000188:drug therapy; D012507:Sarcoidosis / Q000188:drug therapy; D012595:Scleroderma, Systemic / Q000188:drug therapy; D012829:Silicosis / Q000188:drug therapy; D012832:Silo Filler's Disease / Q000188:drug therapy